These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 28392019)
41. Regression of uraemic pruritus by cyclosporin treatment in a haemodialysis patient. Fusaro M; Munaretto G; Spinello M; Gallieni M Nephrol Dial Transplant; 2004 May; 19(5):1338-9. PubMed ID: 15102989 [No Abstract] [Full Text] [Related]
49. Kinetics of phenols in body fluid compartments during hemodialysis. Erben J; Schück O; Brátová M; Moucka P; Palicka V; Fixa P; Hájková B; Herout V; Stilec R; Zahradník J Artif Organs; 1995 Jun; 19(6):544-6. PubMed ID: 8526794 [TBL] [Abstract][Full Text] [Related]
50. Removal of protein-bound uraemic toxins by haemodialysis. Niwa T Blood Purif; 2013; 35 Suppl 2():20-5. PubMed ID: 23676831 [TBL] [Abstract][Full Text] [Related]
51. Effect of ferric polymaltose complex as a phosphate binder in haemodialysis patients. Chang JM; Hwang SJ; Tsai JC; Chen HC; Guh JY; Lai YH Nephrol Dial Transplant; 1999 Apr; 14(4):1045-7. PubMed ID: 10328515 [No Abstract] [Full Text] [Related]
52. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Alhamdani MS Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350 [TBL] [Abstract][Full Text] [Related]
53. Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients. Giardini O; Taccone-Gallucci M; Lubrano R; Ricciardi-Tenore G; Bandino D; Silvi I; Ruberto U; Casciani CU Nephron; 1984; 36(4):235-7. PubMed ID: 6709116 [TBL] [Abstract][Full Text] [Related]
54. Serum levels of immunoreactive gastric inhibitory polypeptide and insulin in uraemic patients. Matthaei D; Ebert R; Schauder P; Frerichs H; Creutzfeldt W; Scheler F Proc Eur Dial Transplant Assoc; 1977; 14():550-6. PubMed ID: 233949 [No Abstract] [Full Text] [Related]
55. Secondary hyperparathyroidism in uraemic patients on chronic haemodialysis--a case report and review. Lim YK Singapore Med J; 1973 Jun; 14(2):99-103. PubMed ID: 4741441 [No Abstract] [Full Text] [Related]
56. Interferon production by leucocytes of dialysed chronic uraemic patients. Gál G; Toth M; Toth S Proc Eur Dial Transplant Assoc; 1981; 18():188-92. PubMed ID: 6173878 [No Abstract] [Full Text] [Related]
57. Reduction of the homocysteine plasma concentration by intravenously administered folinic acid and vitamin B(12) in uraemic patients on maintenance haemodialysis. Buccianti G; Bamonti Catena F; Patrosso C; Corghi E; Novembrino C; Baragetti I; Lando G; De Franceschi M; Maiolo AT Am J Nephrol; 2001; 21(4):294-9. PubMed ID: 11509801 [TBL] [Abstract][Full Text] [Related]
58. Neuromuscular changes in uraemic patients treated with diet therapy and haemodialysis after successful renal transplantation. Ahonen RE; Kock B Proc Eur Dial Transplant Assoc; 1977; 14():568-70. PubMed ID: 341146 [No Abstract] [Full Text] [Related]
59. Long-term haemodialysis treatment with sodium removal by convection. Locatelli F; Pedrini L; Ponti R; Costanzo R; Di Filippo S; Marai P; Pozzi C; Bonacina GP Proc Eur Dial Transplant Assoc; 1981; 18():146-52. PubMed ID: 7329962 [TBL] [Abstract][Full Text] [Related]
60. Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis. Shahapuni I; Esper NE; Opisiv R; Massy Z; Choukroun G; Garabedian M; Fournier A Nephrol Dial Transplant; 2008 Apr; 23(4):1456-7; author reply 1457-8. PubMed ID: 18039645 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]